Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Improved Assays in Pain Research Using Native Neurons

Published: Saturday, May 10, 2014
Last Updated: Saturday, May 10, 2014
Bookmark and Share
Cellectricon and Neusentis to present a webinar on May 16, from 11am EDT.

Cellectricon will co-host a webinar with Neusentis, describing the use of native cells to develop an assay with improved physiological relevance over traditional approaches in pain drug discovery research.

Entitled ‘Development of Cell-Based Assays for Pain Drug Discovery Using Native Sensory Neurons’, the webinar will take place on May 16 at 11am EDT; researchers can register at www.cellecticon.com/events.

Cellectricon is creating model systems with native neurons for registering changes in neural activity - both at the cellular and network level - using its Cellaxess® Elektra discovery platform, and Neusentis is a Pfizer Research Unit focusing on pain and sensory disorders.

Webinar participants will gain further understanding of the underlying mechanisms causing chronic pain, and learn more about phenotypic screening approaches in pain research and the use of compound profiling to advance research in the CNS and pain therapeutic fields.

Presentations from Dr Darren Cawkill, Associate Research Fellow at Neusentis, and Dr Paul Karila, VP Discovery Services, Cellectricon, will cover the results from their assay development work. Dr Cawkill will go on to present data from an additional phenotypic screening case study, which describes the progress towards high-throughput compatible assays using both primary rat neuronal cultures and human stem cell-derived sensory neurons. There will also be a discussion on how such phenotypic screening assays could be integrated into drug discovery programs.

Aimed at R&D scientists working in drug discovery, neuroscience, translational science, high content biology, electrophysiology and ion channel research, ‘Development of Cell-Based Assays for Pain Drug Discovery Using Native Sensory Neurons’, will take place at 11am EDT on May 16.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Cellectricon, Neurexpert Announce Collaboration
Cellectricon and Neurexpert will co-promote their combined CNS drug discovery expertise, with a particular focus on synaptic function assays, for research into treatments of central nervous system disorders in the fields of psychiatry, neurology, pain and neurodegeneration.
Wednesday, June 08, 2016
Cellectricon and Neurexpert Collaborate To Offer Enhanced offering In CNS Drug Discovery
Company has announced its collaboration with Neurexpert Ltd to provide of advanced cell-based discovery services.
Wednesday, June 08, 2016
Cellectricon Establishes Scientific Advisory Board to Enhance Its Pain and CNS Discovery Services
The company, a leading provider of advanced cell-based discovery services, has appointed Dr Edwin Johnson, Director of The Stockholm Brain Institute, as the first member of its new Scientific Advisory Board.
Thursday, July 09, 2015
UCL’s Novel Approach to Research in Biologically-Relevant Models
Cellectricon and UCL unite to present a webinar, March 27, 11am-12pm EDT.
Wednesday, March 19, 2014
Cellectricon Announces Project Grant Winners
The grant was awarded for project proposals utilizing Cellectricon’s Cellaxess ACE technology for the delivery of non-genetic material to adherent cells and cultures.
Thursday, September 19, 2013
Presenting Phenotypic Screening Strategies for Chronic Pain Research
Cellectricon explores novel phenotypic assay designs in a webinar, 5 September, 11am-12pm (EDT).
Wednesday, August 21, 2013
Cellectricon Launches Grant to Fund Electroporation-based Research
New Cellaxess® Project Grant supports advanced research projects.
Wednesday, July 10, 2013
Identifying Unknown Modulators of Pain with New Phenotypic Assays
Cellectricon presentation: SMi Pain Therapeutics conference, 20 May, 11am.
Tuesday, May 14, 2013
Dr. Paul Karila appointed Head of Discovery Services at Cellectricon AB
Discovery services will be based on automated cellular electric field manipulation for novel screening applications.
Wednesday, June 13, 2012
Cellectricon Receives Milestone Order for Cellaxess®HT High Throughput RNAi Screening System
Cellectricon receives the largest single order to deliver three Cellaxess®HT systems to a leading US biotech firm.
Friday, November 14, 2008
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Core-Shell Columns in HPLC: Food Analysis Applications
Explore the most recent applications of core-shell columns in food analysis.
Review of the Analysis of Haemoglobin A1c for Diabetes Diagnostics
This paper aims to clarify methods, units, quality requirements, reference and cutoff limits for hemoglobin A1c (HbA1c) and ratio of blood glucose/HbA1c on the basis of the results from Finnish quality control surveys by comparing them to the literature.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
New Centre Offers Ultra-Speed Protein Analysis
UW-Madison researchers to establish development centre for next-gen protein measurement technologies.
Disrupting Tumour-Promotion in Humans
Researchers have modified an existing protein to represses a specific cancer-promoting ‘message’ within cells.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Vaccine Strategy Targets Multiple Influenza Viruses
Scientists have identified vaccine-induced antibodies that can neutralize strains of influenza virus that infect humans.
Connectome Map More Than Doubles Human Cortex’s Known Regions
Researchers at NIH have developed software that automatically detects the “fingerprint” of each of these areas in an individual’s brain scans.
Discovered Through ‘Big Data’ Analysis
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!